This company seems to have been delisted
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Reason: Acquired by Ipsen
Last recorded trade on: May 5, 2023
Source: https://www.ipsen.com/press-releases/ipsen-completes-acquisition-of-albireo-expanding-the-scope-of-its-rare-disease-portfolio/
Albireo Pharma
ALBO
$69.13
Share price
0.00%
Change (1 day)
124.93%
Change (1 year)
Categories
Operating Margin for Albireo Pharma (ALBO)
Operating Margin as of March 2025 (TTM): -235.11%
According to Albireo Pharma's latest financial reports and stock price the company's current Operating Margin is -235.11%. At the end of 2021 the company had an Operating Margin of -83.86%.
Operating Margin history for Albireo Pharma from 2018 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -83.86% | -93.53% |
| 2020 | -1,295.53% | 99.05% |
| 2019 | -650.86% | 79.9% |
| 2018 | -361.78% | -99.99% |
| 2017 | -2,420,200.00% | 1688453.09% |
| 2016 | -143.33% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.